TreeWAS – Variant ID: rs543650

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F43.2 Adjustment disorders	0.000	0.936	0.064
F43 Reaction to severe stress, and adjustment disorders	0.000	0.954	0.046
F43.9 Reaction to severe stress, unspecified	0.000	0.958	0.042
F43.0 Acute stress reaction	0.000	0.963	0.037
F43.8 Other reactions to severe stress	0.000	0.967	0.033
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.029	0.971	0.000
F43.1 Posttraumatic stress disorder	0.000	0.971	0.029
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.015	0.985	0.000
S82.60 Fracture of lateral malleolus (closed)	0.000	0.985	0.015
K10.2 Inflammatory conditions of jaws	0.010	0.990	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.990	0.010
K10.8 Other specified diseases of jaws	0.009	0.991	0.000
K10 Other diseases of jaws	0.008	0.992	0.000
I95.1 Orthostatic hypotension	0.000	0.993	0.007
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.993	0.007
K10.9 Disease of jaws, unspecified	0.007	0.993	0.000
K10.1 Giant cell granuloma, central	0.007	0.993	0.000
N60.3 Fibrosclerosis of breast	0.000	0.994	0.006
N60.1 Diffuse cystic mastopathy	0.000	0.994	0.006
T43.3 Phenothiazine antipsychotics and neuroleptics	0.006	0.994	0.000
K10.0 Developmental disorders of jaws	0.006	0.994	0.000
K10.3 Alveolitis of jaws	0.006	0.994	0.000
N60 Benign mammary dysplasia	0.000	0.994	0.006
M25.51 Pain in joint (Shoulder region)	0.006	0.994	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.994	0.006
D48.6 Breast	0.000	0.995	0.005
N60.4 Mammary duct ectasia	0.000	0.995	0.005
S82.6 Fracture of lateral malleolus	0.000	0.995	0.005
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.995	0.005
N60.2 Fibroadenosis of breast	0.000	0.996	0.004
N60.0 Solitary cyst of breast	0.000	0.996	0.004
Z22.5 Carrier of viral hepatitis	0.004	0.996	0.000
N60.9 Benign mammary dysplasia, unspecified	0.000	0.996	0.004
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.004	0.996	0.000
N60.8 Other benign mammary dysplasias	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
F44 Dissociative [conversion] disorders	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
H05.0 Acute inflammation of orbit	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.996	0.000
F48 Other neurotic disorders	0.000	0.996	0.003
T45.2 Vitamins, not elsewhere classified	0.003	0.996	0.000
F44.4 Dissociative motor disorders	0.000	0.997	0.003
F40 Phobic anxiety disorders	0.000	0.997	0.003
F44.9 Dissociative [conversion] disorder, unspecified	0.000	0.997	0.003
F42 Obsessive-compulsive disorder	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
N36.8 Other specified disorders of urethra	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.003	0.997	0.000
F44.8 Other dissociative [conversion] disorders	0.000	0.997	0.003
F44.7 Mixed dissociative [conversion] disorders	0.000	0.997	0.003
F44.6 Dissociative anaesthesia and sensory loss	0.000	0.997	0.003
F44.3 Trance and possession disorders	0.000	0.997	0.003
F44.2 Dissociative stupor	0.000	0.997	0.003
F44.1 Dissociative fugue	0.000	0.997	0.003
S82.61 Fracture of lateral malleolus (open)	0.000	0.997	0.003
L02 Cutaneous abscess, furuncle and carbuncle	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
F44.5 Dissociative convulsions	0.000	0.997	0.003
Y85 Sequelae of transport accidents	0.000	0.997	0.003
F40.9 Phobic anxiety disorder, unspecified	0.000	0.997	0.003
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
F42.2 Mixed obsessional thoughts and acts	0.000	0.997	0.003
C84.0 Mycosis fungoides	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
K37 Unspecified appendicitis	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
F48.8 Other specified neurotic disorders	0.000	0.997	0.003
F48.1 Depersonalisation-derealisation syndrome	0.000	0.997	0.003
F42.1 Predominantly compulsive acts [obsessional rituals]	0.000	0.997	0.003
H05.8 Other disorders of orbit	0.000	0.997	0.003
F40.0 Agoraphobia	0.000	0.997	0.003
F48.0 Neurasthenia	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
F42.8 Other obsessive-compulsive disorders	0.000	0.997	0.003
F40.8 Other phobic anxiety disorders	0.000	0.997	0.003
F40.1 Social phobias	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
F45 Somatoform disorders	0.000	0.997	0.003
H05 Disorders of orbit	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
F44.0 Dissociative amnesia	0.000	0.997	0.002
F48.9 Neurotic disorder, unspecified	0.000	0.997	0.002
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.997	0.003
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.997	0.000
T45.4 Iron and its compounds	0.002	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.997	0.000
H05.4 Enophthalmos	0.000	0.997	0.002
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
F42.0 Predominantly obsessional thoughts or ruminations	0.000	0.997	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.997	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
H02.1 Ectropion of eyelid	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
Z02.8 Other examinations for administrative purposes	0.000	0.998	0.002
F45.3 Somatoform autonomic dysfunction	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
K86.3 Pseudocyst of pancreas	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.000	0.998	0.002
F45.0 Somatisation disorder	0.000	0.998	0.002
T36.4 Tetracyclines	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.002	0.998	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
S86.8 Injury of other muscles and tendons at lower leg level	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
I47.2 Ventricular tachycardia	0.000	0.998	0.002
M77.9 Enthesopathy, unspecified	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
M25.77 Osteophyte (Ankle and foot)	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
F40.2 Specific (isolated) phobias	0.000	0.998	0.002
F45.1 Undifferentiated somatoform disorder	0.000	0.998	0.002
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.000	0.998	0.002
H05.3 Deformity of orbit	0.000	0.998	0.002
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
M77.96 Enthesopathy, unspecified (Lower leg)	0.000	0.998	0.002
M77.94 Enthesopathy, unspecified (Hand)	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
M77.95 Enthesopathy, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
T42.3 Barbiturates	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.000	0.998	0.002
H05.2 Exophthalmic conditions	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.000	0.998	0.002
H05.9 Disorder of orbit, unspecified	0.000	0.998	0.002
I88.9 Nonspecific lymphadenitis, unspecified	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
H05.1 Chronic inflammatory disorders of orbit	0.000	0.998	0.002
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.001	0.998	0.001
M77.92 Enthesopathy, unspecified (Upper arm)	0.000	0.998	0.002
T40.3 Methadone	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.000	0.998	0.002
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
F45.2 Hypochondriacal disorder	0.000	0.998	0.002
M77.93 Enthesopathy, unspecified (Forearm)	0.000	0.998	0.002
F45.4 Persistent somatoform pain disorder	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.000	0.998	0.002
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
S52.50 Fracture of lower end of radius (closed)	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
N63 Unspecified lump in breast	0.000	0.998	0.002
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
I95.8 Other hypotension	0.000	0.998	0.002
I95 Hypotension	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T91.3 Sequelae of injury of spinal cord	0.000	0.998	0.002
M77.99 Enthesopathy, unspecified (Site unspecified)	0.000	0.998	0.002
M77.98 Enthesopathy, unspecified (Other)	0.000	0.998	0.002
M77.90 Enthesopathy, unspecified (Multiple sites)	0.000	0.998	0.002
D48.7 Other specified sites	0.000	0.998	0.002
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
W25.9 Unspecified place	0.000	0.998	0.002
J38.2 Nodules of vocal cords	0.000	0.998	0.002
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.002	0.998	0.000
S81.8 Open wound of other parts of lower leg	0.000	0.998	0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
F42.9 Obsessive-compulsive disorder, unspecified	0.000	0.998	0.002
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.002	0.998	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
S52.60 Fracture of lower end of both ulna and radius (closed)	0.000	0.998	0.002
T40.1 Heroin	0.002	0.998	0.000
N70.0 Acute salpingitis and oophoritis	0.000	0.998	0.002
R73.0 Abnormal glucose tolerance test	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.998	0.002
M25.31 Other instability of joint (Shoulder region)	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
D48.3 Retroperitoneum	0.000	0.998	0.002
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
H53.0 Amblyopia ex anopsia	0.000	0.998	0.002
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T91 Sequelae of injuries of neck and trunk	0.000	0.998	0.002
D48.4 Peritoneum	0.000	0.998	0.002
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.002	0.998	0.000
J98.8 Other specified respiratory disorders	0.002	0.998	0.000
J60-J70 Lung diseases due to external agents	0.002	0.998	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.002	0.998	0.000
W13.9 Unspecified place	0.002	0.998	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.998	0.002
J70 Respiratory conditions due to other external agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.000	0.998	0.001
M22.8 Other disorders of patella	0.000	0.998	0.002
M50.3 Other cervical disk degeneration	0.002	0.998	0.000
N30.0 Acute cystitis	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
M25.56 Pain in joint (Lower leg)	0.000	0.998	0.002
N36.1 Urethral diverticulum	0.001	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
T44.0 Anticholinesterase agents	0.001	0.998	0.000
X49.9 Unspecified place	0.000	0.998	0.002
N36.0 Urethral fistula	0.002	0.998	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.000	0.998	0.001
I95.0 Idiopathic hypotension	0.000	0.998	0.001
J70.1 Chronic and other pulmonary manifestations due to radiation	0.001	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.000	0.998	0.001
T91.4 Sequelae of injury of intrathoracic organs	0.000	0.998	0.001
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.000	0.998	0.001
D62 Acute posthaemorrhagic anaemia	0.002	0.998	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.001	0.998	0.000
J70.0 Acute pulmonary manifestations due to radiation	0.001	0.998	0.000
J86.0 Pyothorax with fistula	0.001	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.001	0.999	0.000
J66 Airway disease due to specific organic dust	0.001	0.999	0.000
J63 Pneumoconiosis due to other inorganic dusts	0.001	0.999	0.000
J65 Pneumoconiosis associated with tuberculosis	0.001	0.999	0.000
Y95 Nosocomial condition	0.000	0.999	0.001
N60-N64 Disorders of breast	0.000	0.999	0.001
D48.1 Connective and other soft tissue	0.000	0.999	0.001
J85.2 Abscess of lung without pneumonia	0.001	0.999	0.000
J86.9 Pyothorax without fistula	0.001	0.999	0.000
M34.9 Systemic sclerosis, unspecified	0.001	0.999	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
K55.0 Acute vascular disorders of intestine	0.000	0.999	0.001
C41.1 Mandible	0.000	0.999	0.001
J70.9 Respiratory conditions due to unspecified external agent	0.001	0.999	0.000
J70.8 Respiratory conditions due to other specified external agents	0.001	0.999	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.001	0.999	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.001	0.999	0.000
K29.5 Chronic gastritis, unspecified	0.000	0.999	0.001
M50.9 Cervical disk disorder, unspecified	0.001	0.999	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.001	0.999	0.000
J64 Unspecified pneumoconiosis	0.001	0.999	0.000
N36 Other disorders of urethra	0.001	0.999	0.000
N70 Salpingitis and oophoritis	0.000	0.999	0.001
D48.0 Bone and articular cartilage	0.000	0.999	0.001
I05.9 Mitral valve disease, unspecified	0.000	0.999	0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.999	0.000
Y52.1 Calcium-channel blockers	0.000	0.999	0.001
J62 Pneumoconiosis due to dust containing silica	0.001	0.999	0.000
E23.2 Diabetes insipidus	0.000	0.999	0.001
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.999	0.001
J70.4 Drug-induced interstitial lung disorder, unspecified	0.001	0.999	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.000	0.999	0.001
T91.9 Sequelae of unspecified injury of neck and trunk	0.000	0.999	0.001
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.999	0.001
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.999	0.001
S06.3 Focal brain injury	0.000	0.999	0.001
J67 Hypersensitivity pneumonitis due to organic dust	0.001	0.999	0.000
M05 Seropositive rheumatoid arthritis	0.001	0.999	0.000
N62 Hypertrophy of breast	0.000	0.999	0.001
Z22 Carrier of infectious disease	0.001	0.999	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.000	0.999	0.001
I95.2 Hypotension due to drugs	0.000	0.999	0.001
S52.6 Fracture of lower end of both ulna and radius	0.000	0.999	0.001
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
M06.32 Rheumatoid nodule (Upper arm)	0.001	0.999	0.000
S52.1 Fracture of upper end of radius	0.000	0.999	0.001
J60 Coalworker's pneumoconiosis	0.001	0.999	0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.001	0.999	0.000
J63.5 Stannosis	0.001	0.999	0.000
J63.4 Siderosis	0.001	0.999	0.000
J63.3 Graphite fibrosis (of lung)	0.001	0.999	0.000
J63.2 Berylliosis	0.001	0.999	0.000
J63.1 Bauxite fibrosis (of lung)	0.001	0.999	0.000
J63.0 Aluminosis (of lung)	0.001	0.999	0.000
J66.8 Airway disease due to other specific organic dusts	0.001	0.999	0.000
J66.2 Cannabinosis	0.001	0.999	0.000
J66.1 Flax-dresser's disease	0.001	0.999	0.000
J66.0 Byssinosis	0.001	0.999	0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.001	0.999	0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.001	0.999	0.000
M05.1 Rheumatoid lung disease	0.001	0.999	0.000
J86 Pyothorax	0.001	0.999	0.000
M05.8 Other seropositive rheumatoid arthritis	0.001	0.999	0.000
W27.6 Industrial and construction area	0.000	0.999	0.001
Z93.6 Other artificial openings of urinary tract status	0.001	0.999	0.000
J69 Pneumonitis due to solids and liquids	0.001	0.999	0.000
A40.9 Streptococcal septicaemia, unspecified	0.001	0.999	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.000	0.999	0.001
G30.8 Other Alzheimer's disease	0.001	0.999	0.000
J62.0 Pneumoconiosis due to talc dust	0.001	0.999	0.000
T91.1 Sequelae of fracture of spine	0.000	0.999	0.001
T46 Poisoning by agents primarily affecting the cardiovascular system	0.001	0.999	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.001	0.999	0.000
M24.54 Contracture of joint (Hand)	0.000	0.999	0.001
H65.2 Chronic serous otitis media	0.000	0.999	0.001
M05.0 Felty's syndrome	0.001	0.999	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.999	0.001
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.001	0.999	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.999	0.001
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.999	0.001
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.999	0.001
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.999	0.001
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.999	0.001
I88.1 Chronic lymphadenitis, except mesenteric	0.001	0.999	0.000
K86.1 Other chronic pancreatitis	0.000	0.999	0.001
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.001	0.999	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
Z22.9 Carrier of infectious disease, unspecified	0.001	0.999	0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.001	0.999	0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.001	0.999	0.000
Z22.2 Carrier of diphtheria	0.001	0.999	0.000
Z22.0 Carrier of typhoid	0.001	0.999	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.001	0.999	0.000
S52.11 Fracture of upper end of radius (open)	0.000	0.999	0.001
H26.8 Other specified cataract	0.001	0.999	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.001	0.999	0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.001	0.999	0.000
J67.7 Air-conditioner and humidifier lung	0.001	0.999	0.000
J67.6 Maple-bark-stripper's lung	0.001	0.999	0.000
J67.5 Mushroom-worker's lung	0.001	0.999	0.000
J67.4 Maltworker's lung	0.001	0.999	0.000
J67.3 Suberosis	0.001	0.999	0.000
J67.1 Bagassosis	0.001	0.999	0.000
J67.0 Farmer's lung	0.001	0.999	0.000
K25.4 Chronic or unspecified with haemorrhage	0.000	0.999	0.001
M34.0 Progressive systemic sclerosis	0.001	0.999	0.000
M06.33 Rheumatoid nodule (Forearm)	0.001	0.999	0.000
D01.3 Anus and anal canal	0.001	0.999	0.000
E23.0 Hypopituitarism	0.000	0.999	0.001
G71.0 Muscular dystrophy	0.000	0.999	0.001
K72.9 Hepatic failure, unspecified	0.000	0.999	0.001
S52.5 Fracture of lower end of radius	0.000	0.999	0.001
Z22.8 Carrier of other infectious diseases	0.001	0.999	0.000
I88 Nonspecific lymphadenitis	0.001	0.999	0.000
M05.18 Rheumatoid lung disease (Other)	0.001	0.999	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.001	0.999	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.001	0.999	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.001	0.999	0.000
M05.14 Rheumatoid lung disease (Hand)	0.001	0.999	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.001	0.999	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.001	0.999	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.001	0.999	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.001	0.999	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.001	0.999	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.001	0.999	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.001	0.999	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.001	0.999	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.001	0.999	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.001	0.999	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.001	0.999	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.001	0.999	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.001	0.999	0.000
M06.34 Rheumatoid nodule (Hand)	0.001	0.999	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.999	0.001
S22.30 Fracture of rib (closed)	0.000	0.999	0.001
S52.61 Fracture of lower end of both ulna and radius (open)	0.000	0.999	0.001
I88.0 Nonspecific mesenteric lymphadenitis	0.001	0.999	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.001	0.999	0.000
J69.1 Pneumonitis due to oils and essences	0.001	0.999	0.000
M05.2 Rheumatoid vasculitis	0.001	0.999	0.000
M06.3 Rheumatoid nodule	0.001	0.999	0.000
M06.0 Seronegative rheumatoid arthritis	0.001	0.999	0.000
M34.8 Other forms of systemic sclerosis	0.001	0.999	0.000
M05.09 Felty's syndrome (Site unspecified)	0.001	0.999	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.001	0.999	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.999	0.001
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.999	0.001
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.001	0.999	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.999	0.001
N36.9 Urethral disorder, unspecified	0.001	0.999	0.000
S86.9 Injury of unspecified muscle and tendon at lower leg level	0.000	0.999	0.001
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
T46.7 Peripheral vasodilators	0.001	0.999	0.000
M05.08 Felty's syndrome (Other)	0.001	0.999	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.001	0.999	0.000
M05.06 Felty's syndrome (Lower leg)	0.001	0.999	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.001	0.999	0.000
M05.04 Felty's syndrome (Hand)	0.001	0.999	0.000
M05.03 Felty's syndrome (Forearm)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations